SIB in Upper Thoracic Esophageal Squamous Cell Carcinoma
This study was designed to predict the toxicity and efficacy of Simultaneous Integrated Boost Intensity-modulated Chemoradiotherapy in Upper Thoracic I-IVA Esophageal Squamous Cell Carcinoma.
Esophageal Squamous Cell Carcinoma
RADIATION: Simultaneous integrated boost intensity-modulated chemoradiotherapy
Toxicity Effect, Toxicity effect defined as over CTCAE 4 grade 3 acute radiation toxicity of esophagitis 2 weeks after completion of 6 weeks of radiation therapy., 8 Weeks
PFS, Time of disease progression or unrecorded time of death due to any cause from the day of admission to the first imaging confirmation, One month|OS, Time from admission to death, One month
This study was designed to predict the toxicity and efficacy of Simultaneous Integrated Boost Intensity-modulated Chemoradiotherapy in Upper Thoracic I-IVA Esophageal Squamous Cell Carcinoma.